Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1. (Q34377352)

1 August 2017

Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1. (English)

1 reference

1 August 2017

7

1 reference

1 August 2017

6

Sophie Lestavel

1 reference

1 August 2017

Janine K Kruit

2

0 references

Albert K Groen

9

object named as

Albert K Groen

1 reference

1 August 2017

Jelske N van der Veen

1

object named as

Jelske N van der Veen

1 reference

1 August 2017

Rick Havinga

3

1 reference

1 August 2017

Julius F W Baller

4

1 reference

1 August 2017

Giovanna Chimini

5

1 reference

1 August 2017

Pieter H E Groot

8

1 reference

1 August 2017

Folkert Kuipers

10

1 reference

1 August 2017

16 December 2004

1 reference

Journal of Lipid Research

1 August 2017

1 reference

1 August 2017

46

1 reference

1 August 2017

526-534

1 reference

1 August 2017

3

1 reference

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

1 August 2017

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

Preferential Utilization of Free Cholesterol From High-Density Lipoproteins for Biliary Cholesterol Secretion in Man

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

Hepatobiliary cholesterol transport is not impaired in Abca1-null mice lacking HDL

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

Increased hepatobiliary and fecal cholesterol excretion upon activation of the liver X receptor is independent of ABCA1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

Relation between hepatic expression of ATP-binding cassette transporters G5 and G8 and biliary cholesterol secretion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

The role of PPARs in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta)--synthesis and biological activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

Fatty acid homeostasis and induction of lipid regulatory genes in skeletal muscles of peroxisome proliferator-activated receptor (PPAR) alpha knock-out mice. Evidence for compensatory regulation by PPAR delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

Increased fecal neutral sterol loss upon liver X receptor activation is independent of biliary sterol secretion in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

Inhibition of cholesterol absorption by SCH 58053 in the mouse is not mediated via changes in the expression of mRNA for ABCA1, ABCG5, or ABCG8 in the enterocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

Control of cholesterol turnover in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

Reduced plasma cholesterol and increased fecal sterol loss in multidrug resistance gene 2 P-glycoprotein-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

Effectiveness and tolerability of ezetimibe in patients with primary hypercholesterolemia: pooled analysis of two phase II studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M400400-JLR200

10.1194/JLR.M400400-JLR200

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference